Want to see IMA full AI Analyst Report?
Total Valuation
ImageneBio has a market cap or net worth of $69.97M. The enterprise value is -$3.72M.
Market Cap$69.97M
Enterprise Value-$3.72M
Share Statistics
ImageneBio has 11,279,130 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding11,279,130
Owned by Insiders31.09%
Owned by Institutions39.73%
Financial Efficiency
ImageneBio’s return on equity (ROE) is -0.34 and return on invested capital (ROIC) is -33.39%.
Return on Equity (ROE)-0.34
Return on Assets (ROA)-0.30
Return on Invested Capital (ROIC)-33.39%
Return on Capital Employed (ROCE)-0.34
Revenue Per Employee47.06K
Profits Per Employee-3.08M
Employee Count17
Asset Turnover<0.01
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of ImageneBio is ―. ImageneBio’s PEG ratio is -0.00067.
PE Ratio―
PS Ratio42.01
PB Ratio0.25
Price to Fair Value0.25
Price to FCF-0.70
Price to Operating Cash Flow-1.27
PEG Ratio-0.00067
Income Statement
In the last 12 months, ImageneBio had revenue of 800.00K and earned -45.35M in profits. Earnings per share was -10.76.
Revenue800.00K
Gross Profit-233.00K
Operating Income-48.45M
Pretax Income-45.70M
Net Income-45.35M
EBITDA-44.67M
Earnings Per Share (EPS)-10.76
Cash Flow
In the last 12 months, operating cash flow was -52.08M and capital expenditures 0.00, giving a free cash flow of -52.08M billion.
Operating Cash Flow-52.08M
Free Cash Flow-52.08M
Free Cash Flow per Share-4.62
Dividends & Yields
ImageneBio pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.96
52-Week Price Change-64.63%
50-Day Moving Average5.75
200-Day Moving Average6.57
Relative Strength Index (RSI)52.96
Average Volume (3m)69.52K
Important Dates
ImageneBio upcoming earnings date is Mar 10, 2026, Before Open (Confirmed).
Last Earnings DateNov 12, 2025
Next Earnings DateMar 10, 2026
Ex-Dividend Date―
Financial Position
ImageneBio as a current ratio of 12.49, with Debt / Equity ratio of 6.61%
Current Ratio12.49
Quick Ratio12.49
Debt to Market Cap0.21
Net Debt to EBITDA0.56
Interest Coverage Ratio0.00
Taxes
In the past 12 months, ImageneBio has paid -350.00K in taxes.
Income Tax-350.00K
Effective Tax Rate<0.01
Enterprise Valuation
ImageneBio EV to EBITDA ratio is -0.19, with an EV/FCF ratio of -0.18.
EV to Sales10.80
EV to EBITDA-0.19
EV to Free Cash Flow-0.18
EV to Operating Cash Flow-0.18
Balance Sheet
ImageneBio has $117.21M in cash and marketable securities with $8.15M in debt, giving a net cash position of $109.06M billion.
Cash & Marketable Securities$117.21M
Total Debt$8.15M
Net Cash$109.06M
Net Cash Per Share$9.67
Tangible Book Value Per Share$27.33
Margins
Gross margin is 0.00%, with operating margin of -6056.38%, and net profit margin of -5668.63%.
Gross Margin0.00%
Operating Margin-6056.38%
Pretax Margin-5712.38%
Net Profit Margin-5668.63%
EBITDA Margin-5583.25%
EBIT Margin-5712.38%
Analyst Forecast
The average price target for ImageneBio is $13.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$13.00
Price Target Upside120.34% Upside
Analyst ConsensusModerate Buy
Analyst Count3
Revenue Growth Forecast―
EPS Growth Forecast49.30%